View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Analysis
January 26, 2022updated 30 Jun 2022 1:49pm

Africa has seen the largest growth in women’s health-related trials over the past decade

We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.

By Saywah Mahmood

Africa has seen a 433% increase in the number of women’s health trials taking place over the past decade, the largest increase for any region worldwide.

The region now ranks in fourth for the total number of trials taking place, compared to its sixth placed ranking in 2010.

These figures come from GlobalData’s extensive clinical trials database which seeks to track the number of clinical trials taking place in countries around the world, in numerous therapy areas.

Africa

Africa saw the biggest increase in women's health related trials.

Between 2010 and 2020, there was a 433% increase in the number of trials taking place.

In 2020, the largest proportion of trials in the region took place in Egypt with 79.7% of all trials in the region taking place there.

Nigeria and Cameroon had the next largest percentage of trials taking place in the region with 7.8% and 1.6%, respectively.

Asia-Pacific

The Asia-Pacific region saw a 288% increase in the number of women's health trials taking place.

China saw the largest amount of trials taking place, in 2020, at 54.3%.

Trials in India and Japan also made up a large proportion of the trials taking place with 27.3% and 4.6%, respectively.

Middle East

The Middle East saw a 30% increase in the number trials taking place.

Iran, Israel and Syria made up the most trials in the region, with 83%, 8% and 1.8%, respectively.

Europe

Europe saw a 12% decrease in women's health related trials taking place.

Russia saw the largest percentage of trials taking place in the region at 14.3%.

Spain and France also made up a significant proportion of the trials taking place.

South and Central America

South and Central America saw a decrease in the number of women's health trials.

The region saw a 14% decrease in the number of trials.

Brazil made up 66.7% the largest proportion of trials taking place in the region.

Chile and Guatemala also made up a large amount of the trials taking place with 25% and 8.3%, respectively.

North America

North America saw the biggest decrease in women's health trials.

The number of trials in the region fell by 17% between 2010 and 2020.

The United States saw the largest percentage of trials taking place in the region with 91.9%.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology